In January 2024, the FDA updated its guidance on CAR-T therapies, emphasizing the need for enhanced safety and quality measures. This update followed a series of warnings regarding the risk of T cell ...
T cells play a big role in bringing cell and gene therapies to patients. Despite this clinical potential, scientists developing T cell therapies such as chimeric antigen receptor (CAR)-T cells, ...
Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...
In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Ribosomes—the tiny factories that build proteins in our cells—don't all work with the same efficiency. Researchers from Japan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback